These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9781154)

  • 21. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Second malignancies in patients treated for Hodgkin's disease].
    Keresztes K; Miltényi Z; András C; Illés A
    Magy Onkol; 2002; 46(3):247-51. PubMed ID: 12368920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Late complications of treatment for Hodgkin's disease in children and adolescents].
    Balwierz W; Moryl-Bujakowska A
    Przegl Lek; 2006; 63(1):31-6. PubMed ID: 16892897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of pediatric Hodgkin's lymphoma.
    Hudson MM; Donaldson SS
    Semin Hematol; 1999 Jul; 36(3):313-23. PubMed ID: 10462331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol].
    Moryl-Bujakowska A; Balwierz W; Sztefko K
    Przegl Lek; 2004; 61 Suppl 2():81-4. PubMed ID: 15686053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
    Donaldson SS; Link MP; Weinstein HJ; Rai SN; Brain S; Billett AL; Hurwitz CA; Krasin M; Kun LE; Marcus KC; Tarbell NJ; Young JA; Hudson MM
    J Clin Oncol; 2007 Jan; 25(3):332-7. PubMed ID: 17235049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes.
    Frankovich J; Donaldson SS; Lee Y; Wong RM; Amylon M; Verneris MR
    Biol Blood Marrow Transplant; 2001; 7(1):49-57. PubMed ID: 11215699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
    Schellong G; Riepenhausen M
    Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer following treatment of Hodgkin disease].
    Lustman F; Nouwynck C
    Rev Med Brux; 1995; 16(3):138-40. PubMed ID: 7624666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State-of-the-art therapeutics: Hodgkin's lymphoma.
    Connors JM
    J Clin Oncol; 2005 Sep; 23(26):6400-8. PubMed ID: 16155026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hodgkin's disease. The cure and its price].
    Jacquillat C; Auclerc G; Auclerc MF; Weil M
    Rev Prat; 1984 Apr; 34(21):1075-80. PubMed ID: 6718982
    [No Abstract]   [Full Text] [Related]  

  • 32. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003.
    Jantunen E; Itälä M; Siitonen T; Koivunen E; Leppä S; Juvonen E; Kuittinen O; Lehtinen T; Koistinen P; Nyman H; Nousiainen T; Volin L; Remes K
    Eur J Haematol; 2006 Aug; 77(2):114-9. PubMed ID: 16856906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Solid tumours after treatment for Hodgkin's disease (author's transl)].
    Unger PF; Auclerc G; Weil M; Jacquillat C
    Nouv Presse Med; 1981 Apr; 10(18):1463-7. PubMed ID: 7255119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in people with Hodgkin's disease.
    Yellen SB; Cella DF; Bonomi A
    Oncology (Williston Park); 1993 Aug; 7(8):41-5; discussion 46, 50-2. PubMed ID: 8398634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cured from Hodgkin's disease].
    Brice P
    Bull Cancer; 2002; 89(7-8):666-70. PubMed ID: 12206979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
    Wadehra N; Farag S; Bolwell B; Elder P; Penza S; Kalaycio M; Avalos B; Pohlman B; Marcucci G; Sobecks R; Lin T; Andrèsen S; Copelan E
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1343-9. PubMed ID: 17162217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hodgkin's disease: complications of therapy and excess mortality.
    Hoppe RT
    Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
    Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
    J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.